Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01974154 · ClinicalTrials.gov registry record
COPD Metabolome, Smoking Oxidants and Aberrant Ciliated Cell Function
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- 206
- Enrollment target
NCT01974154 is a clinical trial that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 206 participants.
The verdict
NCT01974154 was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- 206 participants
- Enrollment target
Study Summary
Cigarette smoking is the major cause of chronic obstructive pulmonary disease (COPD), the 4th cause of mortality in the US. Central to COPD pathogenesis is "ciliopathy", dysfunction of the airway ciliated cells that mediate transport of mucus to remove inhaled pathogens. The focus of this study is to carry out metabolic profiling of banked biologic samples and assess the hypothesis that COPD is associated with a unique metabolome in serum and lung epithelial lining fluid, and that subsets of the COPD metabolome are linked to the ciliopathy of COPD.
Interventions
- OTHER Cohort I
- OTHER Cohort II
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2013-12 |
| Est. Completion | 2019-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01974154
The ClinicalTrials.gov registry entry for NCT01974154 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cohort I is the first listed.
NCT01974154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01974154 about?
NCT01974154 is a clinical study titled "COPD Metabolome, Smoking Oxidants and Aberrant Ciliated Cell Function". Cigarette smoking is the major cause of chronic obstructive pulmonary disease (COPD), the 4th cause of mortality in the US. Central to COPD pathogenesis is "ciliopathy", dysfunction of the airway ciliated cells that mediate transport of mucus to remove inhaled pathogens. The focus of this study is t...
What is the current status of trial NCT01974154?
This trial is currently terminated. The enrollment target is 206 participants. The study started on 2013-12. Estimated completion is 2019-05.
What interventions are being tested in trial NCT01974154?
The interventions under investigation include: Cohort I (OTHER), Cohort II (OTHER).
Who is sponsoring clinical trial NCT01974154?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.